Publikationen in Zusammenarbeit mit Forschern von Universidad Autónoma de Madrid (10)

2023

  1. Promising biomedical subcutaneous delivery system in opioid disaccustom process: In vitro/in vivo evaluation of naloxone microparticles on antagonist effect of morphine

    International Journal of Pharmaceutics, Vol. 635

2019

  1. Investigation on the Existence of Sex-By-Formulation Interaction in Bioequivalence Trials

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 5, pp. 1099-1112

2015

  1. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles

    International Journal of Pharmaceutics, Vol. 480, Núm. 1-2, pp. 27-36

  2. Overcoming glucocorticoid resistances and improving antitumor therapies: Lipid and polymers carriers

    Pharmaceutical Research, Vol. 32, Núm. 3, pp. 968-985

2012

  1. Differences in lercanidipine systemic exposure when administered according to labelling: In fasting state and 15 minutes before food intake

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 7, pp. 1043-1047

2005

  1. Biodegradable additives modulate ganciclovir release rate from PLGA microspheres destined to intraocular administration

    Letters in Drug Design and Discovery, Vol. 2, Núm. 2, pp. 148-149

1991

  1. Dissolution kinetics of bezafibrate in two solid forms for oral administration.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 371-378

  2. In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 379-384

  3. Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics.

    European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 389-396

1980

  1. INFLUENCIA DE pH Y AGENTES SOLUBILIZANTES EN LA ESTABILIDAD DEL FENOBARBITAL

    Bollettino Chimico Farmaceutico, Vol. 119, Núm. 7, pp. 405-416